OTC · HCLC
Health-Chem Corporation
Healthcare · Medical - Diagnostics & Research
$0.00
Up+$0.00 (+0.00%)
Updated Aug 17, 2026, 12:18 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 73.99K
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 260
- Avg. volume
- 4
Price performance
HCLC price history
1M range · 0 trading sessions · Daily adjusted prices
HCLC does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest HCLC news
The latest Smart Investors Daily articles mentioning HCLC.
Stock researchCompany · Overview
HCLC research
Overview
Company profile and research snapshot.
Company profile
Health-Chem Corporation, through its subsidiary, Transderm Laboratories Corporation, engages in the research, development, manufacture, and marketing of transdermal drug delivery systems in the United States. It offers transdermal nitroglycerin patches used for transdermal relief of the vascular and cardiovascular symptoms related to angina pectoris (chest pain). The company also conducts research and development activities for third parties on a contract basis. Health-Chem Corporation markets its products directly to wholesalers, distributors, retail pharmacy chains, mail order pharmacies, and group purchasing organizations, as well as indirectly to independent pharmacies, managed care organizations, hospitals, nursing homes, and pharmacy benefit management companies. The company was founded in 1970 and is based in Emigsville, Pennsylvania.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
